When does BIOFRONTERA AG (B8FK.DE) report earnings?
BIOFRONTERA AG (B8FK.DE) will report earnings on 2026-03-31, after the market close.
BIOFRONTERA AG (B8FK.DE) Forecast, Price Target & Analyst Ratings
FRA:B8FK • DE000A4BGGM7
Current stock price
2.6 EUR
-0.09 (-3.35%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BIOFRONTERA AG (B8FK.DE).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of €2.60 to mean target of N/A, Based on 7 analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
N/A
3 Months
N/A
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
82.86%
B8FK.DE was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about B8FK.DE.
In the previous month the buy percentage consensus was at a similar level.
B8FK.DE was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Mar 31, 2026
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|
| Revenue YoY % growth | 25.738M -10.59% | 32.249M 25.30% | 21.666M -32.82% | 52.094M 140.44% | |
| EBITDA YoY % growth | 2.248M 119.51% | 5.878M 161.48% | -4.677M -179.57% | 10.404M 322.45% | |
| EBIT YoY % growth | 1.502M 110.14% | 5.088M 238.75% | -5.517M -208.43% | 9.996M 281.19% | |
| Operating Margin | 5.84% | 15.78% | -25.46% | 19.19% | |
| EPS YoY % growth | N/A -9.16% | N/A 100.69% | N/A -4.34% | 0.11 124.55% |
All data in EUR
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
BIOFRONTERA AG / B8FK.DE Forecast FAQ
Can you provide the consensus rating for BIOFRONTERA AG stock?
The consensus rating for BIOFRONTERA AG (B8FK.DE) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.